Clinical Supply Drugs Regulation 
Worldwide Clinical Trials
NOVEMBER 12, 2024
While clinical supply is essential to any successful trial, autologous cell therapy trials occupy the far end of the spectrum regarding risk tolerance. The process, from patient coordination through manufacturing and administration, is intricate, time-sensitive, and highly regulated.
Pharmaceutical Technology
MAY 24, 2023
This promise and growth are expected to continue as CGT, which have the potential to cover 70% of oncology drugs, are being developed to treat further disease types such as solid tumors. CGT drugs fall into two major categories: autologous and allogeneic. Differences in CGT vs traditional trials supply chain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JUNE 16, 2023
The ongoing chemotherapy drug shortage is a critical situation impacting cancer care in the US. The two drugs are often used in combination to treat many types of cancer, including lung, breast and prostate cancers, as well as many leukemias and lymphomas.
VirTrial
APRIL 18, 2024
The data highlights fast or slow recruitment and how the drug supply is managed. Study data is always subject to scrutiny by regulators, which further highlights its importance. Given the industry is a highly regulated one, there are always new regulations being issued.
XTalks
APRIL 6, 2023
IRT solutions help clinical trial sponsors meet the complexities of patient randomization and clinical supply management. He also shared how modern software development concepts are impacting IRT platforms and transforming the user experience in clinical trials. How is Modern Software Impacting IRT Platforms?
VirTrial
APRIL 18, 2024
The data highlights fast or slow recruitment and how the drug supply is managed. Study data is always subject to scrutiny by regulators, which further highlights its importance. Given the industry is a highly regulated one, there are always new regulations being issued.
VirTrial
APRIL 18, 2024
The data highlights fast or slow recruitment and how the drug supply is managed. Study data is always subject to scrutiny by regulators, which further highlights its importance. Given the industry is a highly regulated one, there are always new regulations being issued.
Expert insights. Personalized for you.
182 
Let's personalize your content